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 Abstract
Objectives: Photodynamic therapy is one of the modern therapeutic techniques, in which cytotoxic effects are 
induced by light. Currently, investigators show that it can be used to eliminate cervical cancer cells. 
Aim: In this study we decided to check whether the Low Level Lasers Therapy (LLLT) can induce the phototoxic 
changes in HeLa cells, after their photosesitization.
Material and methods: The studies were performed in vitro on HeLa cervical cancer cell line. Protoporphyrin IX (PpIX) 
in final concentrations: 0.5, 1.0, 5.0 and 10.0μmol/l was used as photosensitizer. The cells were preincubated with 
specific concentrations for 6 and 18 hours. After these defined periods of time the cultures were illuminated for 8 
minutes by laser light (635nm and 30mW/cm2). The cytotoxic effects were assessed by a colorimetric test XTT, 24 
and 48 hours after irradiation.
Results: Significantly augmented cytotoxic changes were found in HeLa cells 18 hours after preincubation and 48 
hours after illumination. Moreover, biostimulating laser exposure preceded by preincubation with protoporphyrin IX 
caused the cytotoxic changes in cervical cancer cells. 
Conclusion: The obtained results allow us to assume that photodynamic therapy of cervical cancer using 
biostimulating laser light should be performed 18 hours after the application of protoporphyrin IX. 
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Introduction
Lasers	 –	 the	 source	 of	 coherent	 light	 –	 have	 been	 known	
since	 1960.	Their	 action	 is	 based	 on	 a	 stimulated	 emission	 of	
electromagnetic	radiation.	Laser	light	has	specific	properties,	such	
as	 high	 intensity	 (radiation	 rate),	 monochromatism,	 coherence	
and	small	divergence	of	laser	beam.	These	properties	provide	the	
base	for	use	of	lasers	in	medicine	[1].	
Lasers	can	influence	tissues	in	different	ways	which	allows	
to	 categorize	 lasers	 into	high-powered	ones	 (power	 above	500	
W/cm2),	 used	 for	 tissue	 destruction	 and	 removal	 (cutting,	
vaporization	and	coagulation),	and	low-powered,	biostimulating	
ones	 (power	 below	 500W/cm2),	 used	 in	 physiotherapy,	 sports	
medicine,	dermatology,	rheumatology	and	dentistry	[2].	
Biostimulating	 lasers	 emit	 red	 and	 infrared	 light	 of	
wavelengths	from	632	to	about	900nm.	They	cause	no	thermal	
effects	in	tissue,	unlike	during	laser	surgery.	This	effect	is	called	
pre-thermal	 (specific)	 [3].	 In	 physiotherapy,	 biostimulating	
lasers	 are	 used	 for	 treatment	 of	 inflammatory	 conditions,	
such	 as	 rheumatic	 diseases,	 neuropathies,	 tendinitis,	 fascitis,	
tenosynovitis,	 bursitis,	 entezopathies,	 etc.	 The	 widely	 known	
analgesic	effect	of	laser	light	is	used	for	treatment	of	lesions	from	
overloading	or	degenerative	lesions	in	musculoskeletal	system.	
Laser	light	improves	regeneration	of	tissue,	is	used	for	treatment	
of	 wounds,	 ulcerations	 and,	 in	 cases	 of	 improper	 healing,	 of	
bones	[2].	
Biostimulating	 lasers	 are	 of	 special	 interest	 to	 scientists	
who	treat	cancer	by	photodynamic	therapy	(PDT).	This	method	
involves	a	kind	of	selective	detection	and	destruction	of	 tissue	
sensitized	by	special	dye,	thanks	to	the	photochemical	reactions	
[4].	 Three	 factors	 are	 used	 to	 achieve	 it:	 the	 substance	 with	
photosensitizing	 features,	 the	 photosensitizer,	 the	 light	 of	
appropriate	wavelength	and	 the	oxygen	 [5].	Used	 individually,	
each	of	 the	 factors	 should	be	harmless	 for	 tissue.	Their	 joined	
action	 causes	 toxic	 effect	 on	 tissues,	 based	 mainly	 on	 action	
of	free	radicals,	created	due	to	induction	of	photosensitizer	the	
light	 [6].	 PDT	 is	 used	 for	 the	 treatment	 of	 cancers,	 especially	
melanoma.	
Currently,	 there	 have	 appeared	 some	 scientific	 studies	
concerning	the	use	of	this	method	for	therapy	of	cervical	cancer,	
as	 an	 alternative	 to	 available	 treatment	methods	of	 this	 cancer	
[7].	Search	for	new	treatment	methods	of	cervical	cancer	seems	
to	be	appropriate	since	it	is	a	very	common	tumor,	burdened	with	
a	high	degree	of	mortality	[8].	
The	aim	of	this	work	was	to	investigate	the	potential	of	using	
biostimulating	 lasers	 in	 the	 treatment	 of	 cervical	 cancer	 cells	
after	photosensitization.
Materials and methods
Chemicals 
All	 chemicals	 were	 purchased	 from	 Sigma	 Chemical	
Company	(St.	Louis,	MO).	The	stock	solution	of	protoporphyrin	
IX	 (2.5mmol/l)	 was	 obtained	 by	 dissolution	 in	 dimethyl	
sulfoxide.	The	final	concentrations	(0,5;	1,0;	5,0	and	10,0μmol/l)	
were	 obtained	 directly	 in	 the	 culture	 medium	 at	 the	 time	 of	
incubation.
Cell culture
The	studies	were	performed	on	tumor	HeLa	cells,	obtained	
from	human	epithelial	cervical	cancer	of	a	31-year-old	African	
American	woman,	Henrietta	Lacks,	who	died	 in	1951	[9].	The	
cells	were	cultured	in	RPMI	1640	supplemented	with	5%	FCS,	
2	mmol/l	 L-glutamine,	 100	 μg/ml	 streptomycin	 and	 100	U/ml	
penicillin	 in	 a	 5%	CO2-humidified	 atmosphere	 at	 37oC.	After	
24–48	 hours	 incubation	 the	 cells	 were	 transferred	 to	 96-well	
plates.	 The	 cells	 were	 rinsed	 off	 using	 96%	 solution	 of	 PBS	
(phosphate-buffered	 saline)	 and	 digested	 with	 0.05%	 trypsin	
(3	minutes	 at	 37oC).	 Then,	 trypsin	was	 removed	 and	 the	 cell	
suspension	was	prepared	in	2	ml	of	medium.	The	cells	were	spun	
down	and	the	sediment	was	suspended	in	4	ml	of	fresh	medium.	
The	suspension	was	divided	into	4	test-tubes	and	the	medium	was	
added	to	each	test-tube	in	1:8	proportion.	The	average	density	of	
cells	in	1	ml	of	suspension	was	885	thousand/ml.	Hundred	μl	of	
cell	suspension	was	placed	in	each	well	of	a	96-well	plate.	In	the	
tests	we	used	48-hours	cell	cultures.
 Streszczenie
Wstęp: Terapia fotodynamiczna jest jedną z nowych metod leczniczych, w których efekty cytotoksyczne są 
wywołane przez fotouczulacz po jego aktywacji światłem. Obecnie wskazuje się możliwość zastosowania tej 
metody w celu eliminacji komórek raka szyjki macicy. 
Cel badań: Celem niniejszych badań było sprawdzenie czy lasery niskoenergetyczne mogą zostać wykorzystane 
jako źródło wzbudzenia fotouczulaczy w komórkach raka szyjki macicy. 
Materał i metody: Badania przeprowadzono w warunkach in vitro na linii komórek raka szyjki macicy HeLa. Jako 
substancję fotouczulającą zastosowano protoporfirynę IX (PpIX) o końcowych stężeniach: 0,5, 1,0, 5,0 i 10,0mmol/l. 
Komórki preinkubowano z protoporfiryną IX przez okres 6 i 18 godzin. Po tych czasach zawartą w komórkach 
protoporfirynę IX aktywowano przez 8 minut światłem laserowym (635nm, 30mW/cm2). Komórki inkubowano 
dalsze 24 i 48 godzin a zmiany cytotoksyczne oceniano kolorymetrycznym testem XTT.
Wyniki: Zaobserwowano, że najwyższe efekty cytotoksyczne w komórkach HeLa można otrzymać podczas 18 
godzinnej preinkubacji oraz 48 godzinnej inkubacji po naświetlaniu. Wyniki wskazują na możliwość zastosowania 
laserów biostymulacyjnych w terapii fotodynamicznej komórek raka szyjki macicy.
Wnioski: Uzyskane wyniki pozwalają przypuszczać, że terapię fotodynamiczną raka szyjki macicy przy pomocy 
laserów niskoenergetycznych należy wykonać w czasie 18 godzin od momentu aplikacji protoporfiryny IX.
 Słowa kluczowe: rak szyjki macicy / in vitro / terapia fotodynamiczna / 
      / protoporfiryna IX / lasery niskoenergetyczne / 
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Photodynamic therapy treatment
HeLa	 cells	 were	 preincubated	 for	 6	 or	 18	 hours	 with	
protoporphyrin	 IX	 final	 concentrations	 as	 above.	 After	 this	
period	PpIX	was	photoactivated	by	 laser	 light	 (diode	 laser),	at	
the	wavelength	of	635	nm	and	power	of	30mW/cm2.	
What	is	important,	the	laser	head	was	placed	directly	on	the	
cover	of	96-well	plate.	Irradiation	continued	for	8	minutes	and	
was	the	same	in	all	experiments.	Then,	the	cells	were	incubated	
for	24	or	48	hours.	After	this	period	the	analysis	of	PDT	toxicity	
was	carried	out.	Each	experiment	was	repeated	14	times	and	PDT	
results	were	compared	with	a	control	group	of	cells,	which	were	
incubated	with	non-activated	PpIX.
XTT viability test
The	 viability	 of	 cells	 was	 analyzed	 using	 the	 XTT	
colorimetric	test,	based	on	dynamics	of	reduction	of	XTT	pigment	
(tetrazoline-2,3-bis(2-methoxy-4-nitro-5-sulphophenyl)-2H-5-
carboxyanilide)	by	the	living	cells	and	production	of	the	colorful	
product.	 Intensity	 of	 the	 fluorescence	 was	 measured	 at	 the	
wavelength	of	450nm	[15].	
The	 percentage	 of	 mitochondrial	 activity	 inhibition	 was	
calculated	according	to	the	following	equation:	100−(OD	of	drug	
treated	 cells−OD	 of	medium	 alone/OD	 of	 untreated	 cells−OD	
medium	alone×100);	where	OD	is	optical	density,	untreated	cells	
are	control	cells	[10].
Statistical Analysis
Statistical	analysis	of	the	results	was	done	with	nonparametric	
Kruskal-Wallis	 test	 ANOVA	 (post-test	 Dunn’s)	 using	 the	
STATISTICA	ver.5	software	(Statsoft,	Krakow,	Poland).	P	value	
<0.05	was	considered	statistically	significant.
Results
Influence of protoporphyrin IX concentration and 
preincubation periods on cytotoxic effects in HeLa 
cells/ 24-hour incubation
In	 order	 to	 assess	 influence	 of	 protoporphyrin	 IX	
concentration	and	preincubation	periods	on	cytotoxic	effects	in	
HeLa	cells,	 the	cells	were	preincubated	for	6	or	18	hours	with	
different	concentrations	of	PpIX.	After	these	periods	of	time,	the	
photosensitizer	was	photoactivated	for	8	minutes	by	laser	 light	
wavelength	of	635	nm.	Then,	cells	were	incubated	for	24	hours	
and,	after	 this	period,	we	assessed	 the	percentage	 inhibition	 in	
mitochondrial	activity	using	the	colorimetric	XTT	test.	
Results	 of	 cytotoxicity	 were	 joined	 and	 are	 graphically	
shown	in	Figures	1	and	2.			
Figures	 show	 the	 importance	 of	 preincubation	 time	 of	
cervical	 cancer	 cells	with	 protoporphyrin	 IX.	 In	 the	 case	 of	 a	
6-hour	 exposure	 of	 cells	 to	 photosensitizer,	 the	 inhibition	 in	
mitochondrial	activity	was	low	as	compared	to	the	control	group	
of	cells,	reaching	the	value	of	below	20%.	
Elongation	 of	 preincubation	 time	 to	 18	 hours	 caused	 a	
significantly	higher	cytotoxic	effect	as	compared	 to	 the	6-hour	
preincubation	 (p<0.01).	 In	 the	 highest	 concentration	 of	 PpIX	
used	in	the	study,	10μmol/l,	the	inhibition	reached	34%.	
Use	of	still	higher	concentration	of	protoporphyrin	IX	did	not	
result	in	a	significant	increase	in	the	cytotoxic	effect	(p>0.05).
Influence of protoporphyrin IX concentation and 
preincubation periods on cytotoxic effects in HeLa 
cells/ 48-hours length of incubation
In	 order	 to	 assess	 influence	 of	 protoporphyrin	 IX	
concentration	 and	 preincubation	 periods	 on	 cytotoxic	 effects	
in	 HeLa	 cells,	 the	 cells	 were	 preincubated	 for	 6	 or	 18	 hours	
with	 different	 concentrations	 of	 PpIX.	After	 these	 periods	 the	
photosensitizer	 was	 photoactivated	 for	 8	 minutes	 using	 laser	
light	of	the	wavelength	of	635nm.	Then,	the	cells	were	incubated	
for	48	hours	and,	after	this	period,	we	assessed	the	percentage	of	
mitochondrial	inhibition	by	colorimetric	test,	XTT.	
Results	of	cytotoxicity	were	joined	and	are	shown	graphically	
in	Figures	3	and	4.
Similarly	 to	 the	 case	 of	 24-hour	 incubation,	 the	 figures	
demonstrate	 how	 important	 the	 time	 of	 preincubation	 cervical	
cancer	 cells	 with	 protoporphyrin	 IX	 was.	 In	 the	 case	 of	 the	
6-hour	 exposure	 of	 cells	 to	 photosensitizer,	 the	 percentage	 of	
mitochondrial	 activity	 inhibition,	 as	 compared	 to	 the	 control	
 
Figure 2. Preincubation time: 18 hours. 
 
Figure 1. Preincubation time: 6 hours. 
Nr 7/2011506
P R A C E  O R Y G I N A L N E
  g in eko l og ia
Ginekol Pol. 2011, 82, 503-507
Wołuń-Cholewa M, et al.
group	 of	 cells,	 varied	 between	 20%	 and	 33%.	 Elongation	 of	
preincubation	 time	 to	 18	 hours	 caused	 a	 significantly	 higher	
cytotoxic	 effect	 as	 compared	 to	 the	 6-hour	 preincubation	
(p<0.001).	 The	 effect	 reached	 63%	 when	 the	 highest	 PpIX	
concentration	used	in	the	studies	(10μmol/l)	was	applied.	
Using	still	higher	concentrations	of	protoporphyrin	IX	did	not	
bring	any	significant	increase	in	the	cytotoxic	effect	(p>0.05).
Discussion
Biostimulating	lasers	(LLLT)	cause	mainly	analgetic,	anti-
inflammatory	and	regenerative	effects	on	body	cells.	As	a	result	
of	the	exposure	to	low	and	medium	power	laser	radiation,	both	
molecular	and	cellular	changes	can	be	observed	in	the	cell.	The	
cellular	metabolism	 increases,	 as	 demonstrated	 by	 an	 increase	
in	 adenosine-5´-triphosphate	 (ATP),	 DNA	 and	 RNA	 contents,	
increase	in	the	membrane	enzyme	activity	and	improvement	in	
electrolyte	exchange	between	the	cell	and	external	environment.	
At	 the	 level	 of	 tissue,	 an	 improvement	 of	 blood	 and	 lymph	
circulation,	hyperpolarization	of	nerve	endings	and	stimulation	
of	the	immune	system	can	be	noted.	In	exposed	tissues	collagen	
synthesis	manifests	an	increase.	The	range	of	activities	allows	to	
use	lasers	in	physical	therapy	of	pain	and	inflammations	[11].
At	 this	 point	 it	 ought	 to	 be	mentioned	 the	 cancer	 poses	 a	
complete	contraindication	to	laser	biostimulation	[1].	However,	
the	present	study	indicates	that	biostimulating	lasers	can	be	used	
for	cancer	therapy,	on	condition	that	cancer	cells	had	been	earlier	
photosensitized	by	a	 special	 substance,	 the	photosensitizer.	An	
increase	 in	 the	 use	 of	 LLLT	 for	 treatment	 of	 cancer	 has	 been	
noted	 in	 recent	 years.	 Several	 reports	 point	 to	 the	 fact	 that	
radiation	of	tissue	gives	good	results	in	this	type	of	therapy	due	
to	specific	features	of	laser	light	which	allows	to	direct	the	light	
beam	precisely	at	the	lesion,	without	destroying	the	surrounding	
tissue.	 The	 light	 induces	 the	 photosensitizer	 in	 the	 tissue	
selectively	because	it	is	monochromatic	and	has	high	ability	of	
tissue	penetration.	Low	level	power	of	the	laser	allows	to	avoid	
thermal	destruction	in	tissue,	which	decreases	the	risk	of	healthy	
tissue	damage.	Laser	 light	 can	be	 transferred	 through	 an	optic	
fiber,	which	provides	an	additional	advantage.	This	light	source	
seems	to	be	the	best	solution	for	that	sort	of	therapy	[12].	
Results	of	the	present	study	have	shown	that	photodynamic	
method	 with	 laser	 light	 is	 useful	 for	 destruction	 of	 cervical	
cancer	 cells.	 It	 is	 reflected	 by	 results	 of	 colorimetric	 test	with	
tetrazolium	salts,	XTT.	This	test	serves	to	determine	metabolic	
activity	of	live	cells.	Tetrazolium	salts	are	reduced	to	formazan	
dye	by	mitochondrial	succinate	dehydrogenase.	This	enzyme	is	
active	only	in	the	cells	which	have	an	undisturbed	metabolism	and	
electron	transport	chain.	The	quantity	of	formazan	is	calculated	
photometrically	 and	 it	 correlates	with	 the	number	of	 live	 cells	
[13].	
The	 examined	 HeLa	 cells	 which	 were	 exposed	 to	
photodynamic	therapy	show	inhibition	of	mitochondrial	activity	
in	photosensitizer	concentration	of	0.5	μmol/l	and	upon	6-hour	
period	of	preincubation.	This	effect	has	been	poor,	though.	The	
influence	 of	 PpIX	 on	 cytotoxicity	 is	 well	 shown	 in	 18-hour	
preincubation	and	48-hour	incubation.	On	the	basis	of	XTT	test	
results,	we	can	conclude	that	the	cytotoxic	effect	was	dependent	
on	 photosensitizer	 concentration	 and	 periods	 of	 preincubation	
and	incubation.	
What	 proved	 important	 was	 that	 each	 time	 the	 period	
of	 exposure	 to	 laser	 light	 was	 quite	 short	 (8	 minutes),	 which	
manifests	 the	 high	 capacity	 of	 laser	 to	 excite	 photosensitizer	
molecules.	
These	results	allow	us	to	state	that	photodynamic	therapy	is	
a	good	way	 to	destroy	cervical	cancer	cells.	The	pre-condition	
for	 therapy	 effectiveness	 involves	 application	 of	 the	 proper	
PpIX	concentration	and	an	appropriate	period	of	 time	between	
application	 of	 the	 photosensitizer	 and	 radiation.	 It	 must	 be	
remembered,	however,	that	these	experiments	were	conducted	in	
vitro.	Acceptance	of	the	hypothesis	on	efficacy	of	photodynamic	
therapy	in	cervical	cancer	treatment	requires	similar	studies	to	be	
performed	in	vivo.	The	references	and	the	fact	that	photodynamic	
therapy	 is	 accepted	 as	 a	 form	of	 therapy	 of	 cervical	 cancer	 in	
Japan,	allow	us	to	accept	this	hypothesis	[14].	
 
Figure 4. Preincubation time: 18 hours. 
 
Figure 3. Preincubation time: 6 hours. 
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This	work	proves	the	effectiveness	of	photodynamic	therapy	
on	cancer	cells	in	in	vitro	conditions.	These	experiments	can	be	
treated	 as	 an	 introduction	 to	 the	 clinical	 use	 of	 photodynamic	
elimination	 of	 cancer	 cells.	An	 important	 problem	 will	 be	 to	
determine	whether	effective	elimination	of	cells	takes	place	also	
in	 in	vivo	conditions.	It	 is	necessary	 to	encourage	independent	
investigators	 to	 examine	 photodynamic	 therapy	 in	 order	 to	
improve	its	efficacy.
Conclusion
1.	 Photodynamic	 therapy	 is	 an	 effective	 method	 of	
destroying	cervical	cancer	cells.	
2.	 Biostimulating	 lasers	 are	a	proper	 source	of	 light	 to	be	
used	to	destroy	cervical	cancer	cells,	providing	that	cells	
were	earlier	photosensitized	by	protoporphyrin	IX.
3.	 The	most	important	condition	to	ensure	high	efficacy	of	
the	method	 is	 to	match	 appropriate	periods	of	 	 time	of	
preincubation	and	incubation	with	protoporphyrin	IX.
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•	 Antykoncepcja	młodocianych
•	 PMS/PMDD
•	 Zaburzenia	miesiączkowania
•	 Endokrynopatie
•	 Infekcje	narządów	płciowych	u	dziewcząt
•	 Dziewczynka	niepełnosprawna	–	specyfika	postępowania	
 ginekologicznego
6 października 2011 zapraszamy na warsztaty 
skierowane do lekarzy i położnych
Tematyka Warsztatów:
•	 Ultrasonografia
•	 Edukacja	seksualna
•	 Dziecko	molestowane	seksualnie
•	 Aspekty	prawne	w	ginekologii	dziecięcej	i	dziewczęcej
•	 Skryning	cytologiczny
•	 Anoreksja-otyłość	–	zaburzenia	wieku	dojrzewania
•	 Suplementacja	witaminowo-minerałowa
Formularz zgłoszeniowy oraz więcej informacji na stronie
www.konferencje2011.pl
P a t r o n a t
Śląski Uniwersytet Medyczny w Katowicach
Polskie Towarzystwo Ginekologiczne
Sekcja Ginekologii Dziecięcej i  Dziewczęcej
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